Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
Status:
Recruiting
Trial end date:
2026-07-30
Target enrollment:
Participant gender:
Summary
This study is to characterize the safety,tolerability, pharmacokinetics(PK),and preliminary
anti-tumor activity of DR30206, in subjects with advanced or metastatic solid tumors